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Background: To investigate retrospectively the clinicopathological characteristics and outcomes of young patients
with large hepatocellular carcinoma after hepatectomy.
Methods: From January 2003 to December 2012, a total of 153 patients with large hepatocellular carcinoma (HCC)
who received liver resection were included in the study. The clinicopathological features were analyzed retrospectively.
The perioperative data were compared between those aged <40 years (the young group) and those aged >40 years
(the older group). Prognostic factors and long-term survival were evaluated.
Results: The young group had more hepatitis B virus-related HCC than the older group (87.2% vs 66.3%, P = 0.031).
In the young group, 15 patients (21.5%) were overweight (body mass index 25 to 29.9 kg/m2) or obese (body
mass index ≥30 kg/m2), and 38 patients (45.8%) were overweight or obese in the older group (P = 0.032). Other
clinicopathological characteristics were similar between the two groups. The perioperative data showed that the
older group had more pulmonary infection after hepatectomy. Vascular invasion and high Edmondson-Steiner grade
were the independent prognostic factors for long-term survival. There was no statistical difference between the young
group and the older group in overall survival and disease-free survival (P = 0.109 and P = 0.087, respectively).
Conclusions: Liver resection for young patients with large HCC was safe and efficacious and should be recommended.
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Hepatocellular carcinoma (HCC) is one of the most
common malignancies worldwide, especially in China.
HCC ranks second as a cause of cancer death overall in
China [1-4]. Many studies have reported that hepatec-
tomy could be performed satisfactorily for large HCC
(>5 cm) with acceptable mortality [5-7]. However, there
are few reports about the clinicopathological features
and outcomes in young patients with large HCC after
hepatectomy, and the significance of hepatectomy for
these patients therefore remains unknown.
In USA and Europe, which are not hepatitis B endemic
areas, patients younger than 40 years of age with large
HCC are reported to be rare;however, young patients with* Correspondence: zjxujiangfeng@hotmail.com
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the clinicopathological features as well as the long-term
outcomes after hepatectomy of young patients with large
HCC, we performed a retrospective study of patients with
large HCC undergoing hepatectomy whose ages were
younger than 40 years (the young group), compared to
those patients aged above 40 years (the older group).Methods
From January 2003 to December 2012, 153 patients with
large HCC (>5 cm) were treated surgically in the Affili-
ated Hospital of Zhejiang University School of Medicine.
Patients younger than 40 years of age (n = 70) were defined
as the young group And patients aged above 40 years
(n = 83) were defined as the older group. Preoperative
evaluation protocol included blood biochemistry, chest
radiography, liver and renal function tests, ultrasonography,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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clearance test.
Liver resection was undertaken in the patients with good
cardiopulmonary and renal function, Pugh–Child’s grades
A and B, and indocyanine green test at 15 min <15%.
All intraoperative and postoperative complications were
reviewed retrospectively through medical records. Com-
plications (Clavien-Dindo gradesI-V) contained ascites,
wound infection, pleural effusion, pulmonary infection,
biliary fistula, liver failure and bleeding. Follow-up data
were obtained by direct communication with patients
after they underwent hepatic resection. All patients were
examined for recurrence by clinical examination, alpha-
fetoprotein (AFP) and ultrasonography. The follow-upTable 1 Clinicopathologic features of 153 patients with large
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P values in bold indicate statistical significance between groups. AFP, alpha-fetoproperiod was calculated from the date of surgery to the date
of either death or last follow-up. Prior informed consent
was obtained from all patients and the study was approved
by the Ethics Committee of Yiwu affiliated hospital of
zhejiang university school of medicine.
Continuous variables were expressed as mean ± SD and
compared using the independent-samples t test. Categor-
ical data analysis used the rank test or chi-square test.
Survival analysis, including overall survival and disease-
free survival, was estimated by the Kaplan-Meier survival
method and compared using the log-rank test. Univariate
and multivariate analysis by the Cox proportional hazard
regression model was used to identify independent prog-
nostic factors. All statistical analyses were performed usinghepatocellular carcinoma
Mean ± SD or number (%) of patients
Older group (n = 83) P value
11(13.3%) 0.196
72(86.7%)


















tein; BMI, body mass index.
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IL, USA). P < 0.05 was considered to be statistically
significant.
Results
Clinicopathologic features of patients with large
hepatocellular carcinoma
The clinicopathologic parameters of the 153 patients with
large HCC who underwent liver resection are shown in
Table 1. The age of the young group was 32 ± 5 years
compared to 55 ± 9 years in the older group. In the young
group, 61 patients (87.2%) had positive hepatitis B in
serologic test results; however, only 55 patients (66.3%)
had positive hepatitis B in the older group. In the young
group, 15 patients (21.4%) were overweight (body mass
index (BMI) 25 to 29.9 kg/m2) or obese (BMI ≥30 kg/m2),
and 38 patients (45.8%) were overweight or obese in the
older group (P = 0.032). Clinicopathologic characteristics,
including size of tumor, vascular invasion, tumor number,
capsular formation, AFP level, liver cirrhosis, and Child-
Pugh classification, showed no statistical difference be-
tween two groups.
Perioperative data
The intraoperative and postoperative data of 153 patients
with large HCC who underwent liver resection are shown
in Table 2. In the young group, non-anatomical resection
was used in 31 (44.3%) patients, and 39 patients (55.7%)
patients had hemihepatectomy or extended hemihepa-
tectomy. In the young group, the surgical resectionTable 2 Perioperative data
Variables
Young gro
Type of surgical resection
Non-anatomical resection 31(4
Hemihepatectomy/extended hemihepatectomy 39(5
Surgical resection margin (cm)
≤1 34(4
>1 36(5
Operative time (minutes) 188
Time for inflow occlusion (minutes) 13








Hospital stay (days) 14margin was ≤1 cm in 34 (48.6%) patients compared to
39 (47%) patients in the older group. The time for
hepatic resection was 188 ± 9 minutes in the young
group compared to 193 ± 23 minutes in the older
group. The volume of blood loss was 1,196 ± 638 ml in
the young group with 36 (51.4%) patients losing <1,000 ml
compared to 1,226 ± 768 in the older group with 39 (47%)
patients losing <1,000 ml. In the young group, 32 (45.7%)
patients had no blood transfusion, the length of hospital
stay was 14 ± 5 days with no hospital death, and the over-
all postoperative complication rate was 23% (16 patients).
In the older group, 30 (36.1%) patients had no blood
transfusion, the length of hospital stay was 16 ± 7 days,
and the overall postoperative complication rate was 22.9%
(19 patients).Postoperative complications
There was no significant difference in the overall postop-
erative complication rate between the two groups (23% vs
22.9%, P = 0.928; Table 3). The common complications
of the two groups were ascites, wound infection, pleural
effusion, pulmonary infection, biliary fistula, liver failure
and bleeding. The most common complication in the
young group was bleeding (8.6%), and the most common
complication in the older group was pulmonary infection
(13.3%). Pulmonary infection showed a significant differ-
ence between the two groups (P = 0.041). The only post-
operative death was caused by liver failure in the older
group (Table 3).Mean ± SD or number (%) of patients





± 9 193 ± 23 0.673
± 11 15 ± 13 0.516







± 5 16 ± 7 0.376
Table 3 Postoperative complications
Number (%) of patients
Complications Young group Older group P value
Overall 16 (23.0%) 19 (22.9%) 0.928
Ascites 2 (2.8%) 1 (1.2%) 0.326
Wound infection 2(2.8%) 2(2.4%) 0.657
Pleural effusion 1(1.4%) 1(1.2%) 0.536
Pulmonary infection 1(1.4%) 11(13.3%) 0.041
Biliary fistula 2 (2.8%) 1(1.2%) 0.326
Liver failure 2(2.8%) 1(1.2%)* 0.326
Bleeding 6(8.6%) 2(2.4%) 0.084
*Caused postoperative death. P values shown in bold indicate statistical
significance between groups.
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with large hepatocellular carcinoma after hepatectomy
The 1-, 3-, and 5-year overall survival rates in the young
group were 93%, 79% and 47%. The 1-, 3-, and 5-year
disease-free survival rates in the young group were 87%,
28% and 17%. The 1-, 3-, and 5-year overall survival rates
in the older group were 85%, 75% and 40%. The 1-, 3-,
and 5-year disease-free survival rates in the older group
were 65%, 36% and 11%. Overall survival and disease-free
survival in the young group and the older group were
similar (P = 0.109 and P = 0.087, respectively; Figure 1).
Variables that might affect overall survival of young
patients with large HCC after hepatic resection were also
analyzed in this study (Table 4). Univariate analysis of
the prognostic factorsfound that patients with liver cir-
rhosis (P = 0.045), vascular invasion (P = 0.017) and high
Edmondson-Steiner grade (P = 0.036) had poorer overall
survival than those without these variables. However,
using multivariate analysis of the prognostic factors thatFigure 1 Cumulative overall and disease-free survival curves after hepa
carcinoma.predicted overall survival status, only presence of vas-
cular invasion (P = 0.031) and high Edmondson-Steiner
grade (P = 0.042) was significant (Table 4).
Discussion
Young patients with large HCC, who are rare in USA
and Europe, are not uncommon at diagnosis in China.
Astudy showed that 30% of HCC patients were younger
than 40 years old [8]; in our cohort this ratio reached
47%. The high liver cancer rates in young patients in
China largely reflect the prevalence of chronic hepatitis
B virus (HBV) infection [9-11]. In this study, the young
group had more HBV-related HCC than the older group
(87.2% vs66.3%, P = 0.031). This implied that HCC in
most young patients was caused by HBV infection. This
infection may even have happened in infancy and has
caused liver cirrhosis after many years. HBV infection
leads to HCC [12-15]; therefore, regular examination of
AFP and B ultrasound is very important for young patients
with a history of hepatitis B infection. It is key for an early
diagnosis and early operative treatment to improve the
survival rate of young HCC patients. In the older group,
there may be other factors involved. In the young group,
15 patients (21.4%) were overweight (BMI 25 to 29.9 kg/
m2) or obese (BMI ≥30 kg/m2), compared to 38 patients
(45.8%) in the older group (P = 0.032). It is implied that
non-alcoholic fatty liver diseases, which are associated
with obesity, may participate in the development of HCC,
especially in older patients [16-19]; therefore, we must pay
more attention to the older patients who are overweight
or obese.
Our study showed that hepatic resection for large HCC
could be performed with an acceptable mortality rate and
postoperative complication rates. The perioperative datatectomy of the young and older patients with large hepatocellular
Table 4 Cox proportional hazard regression analyses for overall survival in young patients with large hepatocellular
carcinoma after hepatectomy
Variables n* Univariateanalysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Gender
Female 17 1 1
Male 53 0.752(0.290-3.547) 0.548 0.721(0.309-3.176) 0.408
Hepatitis B status
Positive 61 1 1
Negative 9 0.963(0.243-4.416) 0.363 0.904(0.262-3.455) 0.789
AFP level (ng/mL)
Negative 21 1 1
Positive 49 1.006(0.561-1.012) 0.053 1.069(0.972-1.108) 0.129
Number of tumors
Single 49 1 1
Multiple 21 1.351(0.739-2.146) 0.053 1.683(0.460-2.373) 0.112
Liver cirrhosis
Absent 38 1 1
Present 32 1.114(1.058-2.934) 0.045 1.137(0.866-2.798) 0.207
Child-Pugh classification
A 56 1 1
B 14 1.237(0.762-2.387) 0.508 1.119(0.428-3.946) 0.623
Vascular invasion
Absent 37 1 1
Present 33 2.112(1.037-3.896) 0.017 2.233(1.010-4.232) 0.031
Edmondson-Steiner grade
Low grade (I and II) 34 1 1
High grade (III and IV) 36 1.560(1.087-3.331) 0.036 1.747(1.235-3.346) 0.042
Surgical resection margin
≤1 cm 34 1 1
>1 cm 36 1.339(0.234-3.642) 0.743 1.366(0.356-2.956) 0.375
Blood loss (ml)
<1,000 36 1 1
≥1,000 34 1.036(0.424-2.986) 0.117 1.352(0.374-3.463) 0.353
Blood transfusion (ml)
Without 32 1 1
With 38 1.008(0.532-1.787) 0.733 1.453(0.834-2.564) 0.656
Complications
Absent 54 1 1
Present 16 0.986(0.330-2.675) 0.559 0.824(0.363-2.863) 0.348
BMI
Normal weight 55 1 1
Overweight/obese 15 1.006(0.687-1.331) 0.309 1.250(0.909-1.671) 0.326
*Number of patients. P values shown in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index; HR, hazard ratio.
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older group had more pulmonary infection after hepatec-
tomy. This implies that hepatectomy for young patients
with large HCC is safe. We also found that the cumulative
overall and disease-free survival curves after hepatectomy
showed no statistical difference between the young and
the older groups. This implies that hepatic resection for
young patients with large HCC is efficacious.
Conclusion
In conclusion, the clinicopathologic characteristics and
the outcome for young patients with large HCC after
liver resection were similar to that of the older patients,
except for differences in infection through HBV and
BMI. Liver resection for young patients with large HCC
is safe and efficacious and should be recommended.
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